A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.

作者: Tamador Elsir , Per‐Henrik Edqvist , Joseph Carlson , Dan Ribom , Michael Bergqvist

DOI: 10.1002/IJC.28441

关键词:

摘要: Recent studies suggest that the regulatory networks controlling functions of stem cells during development may be abnormally active in human cancers. An embryonic cell (ESC) gene signature was found to correlate with a more undifferentiated phenotype several cancer types including gliomas, and associated poor prognosis breast cancer. In present study, we used tissue microarrays 80 low-grade (WHO Grade II) 98 high-grade gliomas Grades III IV) investigate presence ESC-related proteins Nanog, Klf4, Oct4, Sox2 c-Myc by immunohistochemistry. While similar patterns co-expressed between low- were present, up-regulated protein levels Oct4 gliomas. Survival analysis Kaplan-Meier revealed significant shorter survival subgroups astrocytomas (n = 42) high Nanog (p 0.0067) Klf4 0.0368), 85) 0.0042), 0.0447), 0.0078) glioblastomas only 71) 0.0422) 0.0256). multivariate model, identified as an independent prognostic factor 0.0039), 0.0124) 0.0544), together established clinical variables these tumors. These findings provide further evidence for joint pathways identify one key players determining outcome astrocytomas.

参考文章(47)
Hiroko Ohgaki, Paul Kleihues, Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of Neuropathology and Experimental Neurology. ,vol. 64, pp. 479- 489 ,(2005) , 10.1093/JNEN/64.6.479
David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)
Riccardo Soffietti, BG Baumert, L Bello, Andreas Von Deimling, H Duffau, M Frénay, W Grisold, R Grant, F Graus, Khe Hoang‐Xuan, M Klein, Beatrice Melin, J Rees, T Siegal, Anja Smits, Roger Stupp, Wolfgang Wick, None, Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force European Journal of Neurology. ,vol. 17, pp. 1124- 1133 ,(2010) , 10.1111/J.1468-1331.2010.03151.X
Yuji Guo, Shangming Liu, Ping Wang, Shidou Zhao, Fuwu Wang, Lujun Bing, Yanmin Zhang, Eng-Ang Ling, Jiangang Gao, Aijun Hao, Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology. ,vol. 59, pp. 763- 775 ,(2011) , 10.1111/J.1365-2559.2011.03993.X
Ghazaleh Tabatabai, Roger Stupp, Martin J. van den Bent, Monika E. Hegi, Jörg C. Tonn, Wolfgang Wick, Michael Weller, Molecular diagnostics of gliomas: the clinical perspective Acta Neuropathologica. ,vol. 120, pp. 585- 592 ,(2010) , 10.1007/S00401-010-0750-6
Claire Villalva, Ulrich Cortes, Michel Wager, Jean-Marc Tourani, Pierre Rivet, Celine Marquant, Sebastien Martin, Ali G. Turhan, Lucie Karayan-Tapon, O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting Conditions International Journal of Molecular Sciences. ,vol. 13, pp. 6983- 6994 ,(2012) , 10.3390/IJMS13066983
Keriayn N. Smith, Amar M. Singh, Stephen Dalton, Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Cell Stem Cell. ,vol. 7, pp. 343- 354 ,(2010) , 10.1016/J.STEM.2010.06.023
Lynette M. Sholl, Justine A. Barletta, Beow Y. Yeap, Lucian R. Chirieac, Jason L. Hornick, Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. The American Journal of Surgical Pathology. ,vol. 34, pp. 1193- 1198 ,(2010) , 10.1097/PAS.0B013E3181E5E024
Jennifer Nichols, Branko Zevnik, Konstantinos Anastassiadis, Hitoshi Niwa, Daniela Klewe-Nebenius, Ian Chambers, Hans Schöler, Austin Smith, Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 Cell. ,vol. 95, pp. 379- 391 ,(1998) , 10.1016/S0092-8674(00)81769-9
T Elsir, M Qu, S G Berntsson, A Orrego, T Olofsson, M S Lindström, M Nistér, A von Deimling, C Hartmann, D Ribom, A Smits, PROX1 is a predictor of survival for gliomas WHO grade II. British Journal of Cancer. ,vol. 104, pp. 1747- 1754 ,(2011) , 10.1038/BJC.2011.162